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FTA™ technology is widely used across many molecular disciplines for sample 
capture, storage and analysis. The use of this technology for the long-term storage 
of blood samples for DNA analysis was examined as well as its potential to remove 
inhibitors from DNA samples previously extracted from blood with PCR inhibi-
tors remaining. It was found that blood spots stored on FTA™ cards for 8 years at 
room temperature gave successful PCR products and that FTA™ cards are a useful 
tool for removing substances in samples which interfere with or inhibit, the PCR 
reaction.
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Introduction
The generation of numerous DNA sam-
ples from biological specimens is now 
an element in many research projects. 
Preparing and archiving a large collec-
tion of samples for DNA analysis can 
present logistical problems. One solu-
tion is the blood storage medium FTA™ 
Classic Cards. An FTA™ card safely stores 
genomic DNA, in the form of dried spots 
of whole blood, or can be used with 
almost any sample type, including cul-
tured cells, buccal cells, plant material, 
bacteria, plasmids, solid tissue, viral par-
ticles and M13 plaques (www.whatmann.
com). Upon sample application onto the 
cards, cell membranes and organelles are 
lysed and the released nucleic acids are 
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entrapped in the matrix. The nucleic acids 
remain immobilized and are stabilized for 
transport, immediate processing or long-
term storage at room temperature. Stored 
at room temperature, genomic DNA on 
FTA™ is reported by the manufacturers 
to be stable for at least 17 years (www.
whatmann.com). Prior to analysis of the 
bound DNA, the samples are purified by 
washing with FTA™ Purification Reagent 
and removing the stabilising chemicals 
and cellular inhibitors of enzymatic reac-
tions. The FTA™ purification method is 
very mild and similar to detergent based 
protocols (Montgomery and Sise, 1990) 
as compared to traditional phenol based 
purification methods (Maniatis, Fritsch 
and Sambrook, 1989). Since the DNA 
remains bound to the paper, the manipu-
lations to purify the DNA are simpli-
fied and amenable to automation. DNA 
samples on FTA™ cards offer a very com-
pact archival system compared to glass 
vials or plastic tubes in freezers. FTA™ 
technology has also been shown to have 
practically identical limits of detection 
in PCR to those using traditionally extract-
ed DNA (Alhassan et al., 2007). Successful 
PCR is dependant on the sample being 
free of polymerase inhibitors such as hae-
moglobin (Abu Al-Soud and Rådström, 
2001), lactoferrin (Abu Al-Soud and 
Rådström, 2001) and IgG (Abu Al-Soud, 
Jönsson and Rådström, 2000) commonly 
found in blood. As little as 0.004% v/v 
of blood in the PCR reaction is suf-
ficient for complete inhibition to occur 
(Rådström et al., 2003). The occurrence 
of PCR inhibitors in samples post DNA 
extraction has been described for sources 
such as stools (Stauffer et al., 2008) and 
blood (Akane et al., 1994). This present 
study assessed the suitability of FTA™ 
technology for inhibitor removal and long-
term storage (8 years) of DNA at room 
temperature.
Materials and Methods
Reagents
FTA™ reagents were obtained from 
Whatmann and PCR reagents from 
Invitrogen, unless otherwise noted.
Samples
Four samples of dried sheep blood spot-
ted on FTA™ cards in 2000 were tested 
(in 2008) to confirm the long term stabil-
ity of DNA. Four samples of sheep DNA 
that had been extracted using a traditional 
detergent method but contained inhibitors 
were used for the inhibition removal analy-
sis. An individual sample of DNA of known 
quality and quantity was used as both an 
internal amplification control (IAC) and 
an external amplification control (EAC). 
The IAC was used to confirm the presence 
of inhibitors in the pre extracted DNA 
samples, and the EAC was used to confirm 
the correct operation of the equipment 
and reagents used in the PCR.
Preparation of samples from an FTA™ 
card
DNA samples, extracted previously using 
a traditional detergent method, were 
spotted onto FTA™ cards and allowed 
to dry overnight at room temperature. 
Using a Harris Micro-Punch™ apparatus 
with mat (Whatmann), a 1.2 mm diam-
eter punch was taken from dried spots 
from both the freshly spotted extracted 
samples and the samples spotted in the 
year 2000. The micro-punch was cleansed 
with alcohol between punches to prevent 
cross-contamination. The punches were 
processed according to the manufacturer’s 
instructions. Briefly, the punches were 
washed three times with FTA™ purifi-
cation reagent for 5 min at room tem-
perature, followed by two washes with TE 
(10 mM Tris pH 8.0, 0.1 mM EDTA). The 
washed punches were dried for 30 min 
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at 60 °C. Processed FTA™ Card punches 
were assayed immediately.
Amplification
The processed FTA™ punches (1.2 mm 
punches were equivalent to ~20 ng genom-
ic DNA) were placed in PCR tubes, with 
the following components added and the 
final volume adjusted to 50 µL with sterile 
double distilled H2O: 200 nM each primer, 
800 µM DNTPs, 1.5 mM MgCl2 & 2.5 
U Taq polymerase. Using an Eppendorf 
Mastercycler the samples were heated to 
95 °C for 3 min followed by 30 cycles of 
95 °C for 30 s, 63 °C for 30 s, 72 °C for 30 
s, with a final extension step of 72 °C for 
5 min. The reaction products were held at 
4 °C until use, typically within 24 h.
Two primer sets were used in the ampli-
fication, both amplifying segments of the 
BMP15 gene located on the ovine X chro-
mosome; one produced 191 bp DNA frag-
ment and the second produced 141 bp 
DNA fragment (Table 1). 
The PCR products were visualised using 
a 2.5% agarose gel with ethidium bromide 
staining. A DNA marker of known DNA 
fragment sizes (100 bp ladder) was run 
along side the samples to aid in identifica-
tion of the products.
Results and Discussion
In this study, it was found that the FTA™ 
cards enabled successful PCR with DNA 
samples extracted from blood that have 
previously failed to yield PCR products. 
The presence of inhibitors was confirmed 
by the addition of an internal ampli-
fication control to the PCR reaction. 
The absence of the PCR product from 
both of the DNA templates confirmed the 
presence of inhibitors in the test sample. 
This contaminated DNA upon treatment 
with the FTA™ system gave a high quan-
tity of quality PCR products (Figures 
1 and 2). The EAC was successful in all 
cases and produced the desired PCR prod-
uct, confirming that the parameters and 
components in the PCR were correct 
(Figure 1).
Figure 2 shows the amplification of 
191 bp PCR products of an addition-
al four extracted DNA samples which 
were previously known to contain 
inhibitors. 
The DNA that was spotted onto the 
FTA™ cards in year 2000 gave successful 
amplification of the target 191 bp product 
after 8 years stored on FTA™ cards at 
room temperature (Figure 2). 
Samples which have repeatedly failed 
to yield PCR products due to inhibitors 
can be rescued for testing using the FTA™ 
system. Although this testing only encom-
passed removing inhibitors from blood, it 
is most likely that PCR inhibitors found 
for other sample sources such as food or 
feed, and well established problematic 
sources such as urine and faeces, would 
also be removed from the DNA.
FTA™ usefulness for the preservation 
of biological samples for subsequent DNA 
analysis was also examined. It was found 
that DNA from blood samples stored on 
FTA™ classic cards is stable for at least 8 
Table 1. Nucleotide sequences of the primer sets used
Primer name Strand Nucleotide sequence PCR product size (bp)
BMP15F2 Forward 5'-CACTGTCTTCTTGTTACTGTATTTCAATGAGAC-3' 141
BMP15R4 Reverse 5'-GATGCAATACTGCCTGCTTG-3'
BMP15HPYF Forward 5'-GCAGCCAAGAGGTAGTGAGG-3' 191
BMP15HPYR Reverse 5'-CAATACTGCCTGCTTGACGA-3'
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Figure 1. PCR amplification of DNA samples pre- and post-FTA™ purification. 100 bp: 
Molecular size marker (100, 200, 300, 400 bp, etc.). EAC: External amplification control 
(DNA of known quality and quantity was used as a positive control for the PCR). The same 
DNA was used for the internal amplification control (IAC). P1–P2: 141 bp PCR product 
from the DNA samples post-FTA™ purification. P3–P4: Absence of PCR product from both 
the IAC and the sample DNA prior to FTA™ treatment. −ive ctl: Negative control (no DNA 
added).
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Figure 2. PCR amplification of 8-year old blood spots and FTA™ treated DNA samples 
which contained inhibitors. 100 bp: Molecular size marker (100, 200, 300, 400 bp, etc.). 
EAC: External amplification control (DNA of known quality and quantity was used as a 
positive control for the PCR). S1–S4: PCR products from 8-year old blood spots, stored 
using the FTA™ system. S5–S8: 191 bp PCR products from existing DNA samples extracted 
with inhibitors present and purified with the FTA™ system. −ive ctl: Negative control (no 
DNA added).
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years and provided ample PCR products 
for downstream analysis such as sequenc-
ing or genotyping. However, this system 
does have some drawbacks such as limited 
return of DNA from each dried blood spot 
(with approximately 20 ng per 1.2 mm 
diameter punch), and the requirement for 
carrier free genomic DNA and accurate 
DNA concentrations for certain commer-
cial analysis, e.g., SNP (single nucleo-
tide polymorphism) chips and genotyping 
platforms. Therefore, it is still prudent 
to use traditional extraction procedures 
from whole blood as a primary method 
for DNA extraction, where practicable. 
Carrier bound DNA from systems such as 
FTA™ may still be used for DNA demand-
ing applications but will require whole 
genome amplification (WGA) to provide 
sufficient DNA. WGA has been shown 
to have very high concordance (>99.8%) 
with intact genomic DNA (Barker et al., 
2004) when analysed across a 2320 SNP 
panel but has not been proven on all 
commercial platforms and may introduce 
bias to the genotyping results (Dean et al., 
2002). The best use of the FTA™ system 
may lie in a secondary role for process-
ing of samples, e.g., for routine screening 
of established SNPs of importance or 
candidate gene SNP discovery, without 
the need to repeatedly return to the stock 
solutions. It is evident, from considara-
tions such us ease of use, space saving, 
long term stability and storage at room 
temperature, that the FTA™ card tech-
nology is a valuable tool for molecular 
biology.
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